The combination of intravenous Reolysin and gemcitabine induces reovirus replication and endoplasmic reticular stress in a patient with KRAS-activated pancreatic cancer. uri icon

authors

  • Mahalingam, Devalingam
  • Patel, Sukeshi
  • Nuovo, Gerard
  • Gill, George
  • Selvaggi, Giovanni
  • Coffey, Matt
  • Nawrocki, Steffan T

publication date

  • July 10, 2015